FDA Inspection 1007915 — Philadelphia FIGHT IRB

Philadelphia FIGHT IRB — FEI 3002977874

The FDA completed an inspection of Philadelphia FIGHT IRB on Feb 2, 2017 in Philadelphia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 2, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

IRB